Drug can significantly block early stages of COVID-19 in engineered human tissues

Trial drug can significantly block early stages of COVID-19 in engineered human tissues

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Science, Health & Technology

UBC experts on COVID-19

Media Advisories

Feedback-based policy can help manage COVID-19 more effectively

Q&As

Q&A: UBC researchers warn of dangers of air pollution during COVID-19 outbreak

Q&As

Feature Video

Ta-Nehisi Coates

Thinking While Black with Ta-Nehisi Coates

Enjoy the moderated discussion and Q&A session with National Book Award-winning author Ta-Nehisi Coates, second speaker of the 2020 Phil Lind Initiative Speaker Series Thinking While Black.

Opinions

Contraception Pill

Why B.C. should introduce universal contraception coverage in this year’s budget

Morgan Haines and Janice Mok, third-year medical students at UBC and members of the UBC Medicine Political Advocacy Committee, wrote about universal access to contraception.

Find UBC Experts

Latest News

Tweets by @ubcnews

UBC Reports

A weekly summary of the latest stories from UBC News.